Transaction in Own Shares

Science Group PLC
20 September 2024
 

 

 

20 September 2024

 

Science Group plc

(the "Company" or "Science Group")

 

Transaction in own shares

 

 

Science Group plc (AIM:SAG) announces that, on 19 September 2024, it purchased 5,000 of its 1 pence ordinary shares at an average price of 478.0 pence per share. The highest price paid per share was 478.0 pence and the lowest price paid per share was 478.0 pence. The Company purchased these shares through Panmure Liberum Capital Limited.

 

The number of shares purchased represented 0.01% of the voting rights attributable to the total ordinary shares in issue prior to the purchase. The purchased shares will be held in treasury.

 

The total number of ordinary shares in issue (excluding treasury shares) following this announcement is 45,200,242.  Science Group holds 985,632 shares in treasury.

 

The figure of 45,200,242 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the FCA's Disclosure and Transparency Rules.

 

 

Schedule of Purchases - Individual Transactions

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the schedule below contains detailed information about the purchases made by Panmure Liberum Capital Limited on behalf of the Company as part of the buyback programme.

 

Number of shares purchased

Transaction price (per share)

Time of transaction

Execution venue

5000

478.0

16:39:41

AIMX

 

- Ends -

 

For further information:

Science Group plc


Sarah Cole, Company Secretary

Tel: +44 (0) 1223 875 200

 

www.sciencegroup.com  

Stifel Nicolaus Europe Limited (Nominated Adviser and Joint Broker)


Erik Anderson, Nick Harland

Tel: +44 (0) 20 7710 7600



Panmure Liberum Capital Limited (Joint Broker)


Max Jones, John More

Tel: +44 (0) 20 3100 2000




 


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings